Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.

Biotechnology

Education

Scribe Therapeutics

Benjamin L. Oakes

Kristina Oresic Bender

Shilpa Shroff

Ed Sterling II

Michelle Eggers

Sunny Mok

Richard Hector

David Parrot

Vera Switek

Brett T. Staahl

Svetlana Lucas

The Research & Development team at Scribe Therapeutics is dedicated to advancing the engineering and application of CRISPR technologies to address genetic disorders. This multidisciplinary team conducts cutting-edge research, develops innovative CRISPR molecules, and collaborates on therapeutic discovery and formulation, ensuring the translation of scientific breakthroughs into effective treatments. Their work encompasses areas such as CNS biology, liver therapeutics, analytical chemistry, and computational biology, driving the next generation of genetic medicine.

Research & Development

Business Operations

Leadership Team

Research & Development

About

Team members

Other teams at Scribe Therapeutics

Business Operations

Leadership Team